VIA
IRON icon

Virtus Investment Advisers’s Disc Medicine IRON Stock Holding History

Virtus Investment Advisers’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Buy
4,812
+1,845
+62% +$127K 0.08% 347
2026
Q1 		$190K Buy
2,967
+70
+2% +$4.86K 0.05% 395
2025
Q4 		$230K Buy
2,897
+739
+34% +$62.4K 0.06% 359
2025
Q3 		$143K Buy
2,158
+374
+21% +$22.2K 0.04% 384
2025
Q2 		$94.5K Sell
1,784
-772
-30% -$36.3K 0.03% 354
2025
Q1 		$127K Buy
+2,556
New +$142K 0.03% 382

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Virtus Investment Advisers's IRON Position: Q2 2026 in Review

Virtus Investment Advisers increased its Disc Medicine (IRON) stake by 62% in Q2 2026, buying an estimated $127K and bringing the position to 4,812 shares worth $352K. The position accounts for 0.08% of the portfolio, ranked #347.

Virtus Investment Advisers first reported a position in IRON in Q1 2025 and has held it in 6 quarters since. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Virtus Investment Advisers held 4,812 shares of Disc Medicine worth $352K as of Q2 2026.
  • Virtus Investment Advisers bought 1,845 Disc Medicine shares in Q2 2026, an estimated $127K.
  • Disc Medicine made up 0.08% of Virtus Investment Advisers's portfolio in Q2 2026, its #347 holding.
  • Virtus Investment Advisers first reported a position in Disc Medicine in Q1 2025 and has held it in 6 quarters since.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.